Amwell (AMWL) Tops Q2 EPS by 1c

Amwell (NYSE: AMWL) reported Q2 EPS of ($0.25), $0.01 better than the analyst estimate of ($0.26). Revenue for the quarter came in at $64.5 million versus the consensus estimate of $64.13 million.

GUIDANCE:

Amwell sees FY2022 revenue of $275-285 million, versus the consensus of $276.8 million.

For earnings history and earnings-related data on Amwell (AMWL) click here.

You May Also Be Interested In

• Constellation Brands (STZ) Tops Q1 EPS by 18c
• Evercore ISI Upgrades XPO (XPO) to Outperform
• JPMorgan Reiterates Overweight Rating on Adani Ports & Special Economic Zone (ADSEZ:IN)